Net Cash Provided by (Used in) Operating Activities |
-7.4K |
USD |
+79.1% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
7.84K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
295M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
17.7M |
shares |
+3.82% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
-100% |
Q4 2023 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
1.06M |
USD |
+8.49% |
Q4 2023 |
FY 2023 |
Cash and Cash Equivalents, Period Increase (Decrease) |
-2.95K |
USD |
+24.5% |
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
789K |
USD |
+7.01% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
4.39M |
USD |
+2.59% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
0 |
USD |
-100% |
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Interest Expense |
52.8K |
USD |
-0.28% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |